Search results
Zai Lab doses first subject in Phase II plaque psoriasis treatment trial
Clinical Trials Arena via Yahoo Finance· 1 day ago"Zai Lab doses first subject in Phase II plaque psoriasis treatment trial" was originally created...
Finding the Best Psoriasis Treatment: How I Got Psoriasis Relief
Verywell Health via Yahoo News· 3 days agoWith two kids under 2, I needed some relief. I had been through enough psoriasis treatment and had...
Home Phototherapy for Psoriasis: Optimizing Access
Medscape· 2 days agoSupporters of home phototherapy for patients with plaque and guttate psoriasis had plenty to cheer about at the annual meeting of the American Academy of...
Teva and Alvotech Announce SIMLANDI® (adalimumab-ryvk) Injection Now Available in the U.S.
Morningstar· 4 days ago“We are proud to make SIMLANDI available in the U.S. to patients and providers,” said Thomas Rainey...
J&J’s Tremfya meets endpoints in Phase III ulcerative colitis trial
Clinical Trials Arena via Yahoo Finance· 3 days agoJ&J’s Tremfya is expected to be the successor to the company’s IL-12/IL-23 inhibitor Stelara...
Ultravate side effects: What they are and how to manage them
Healthline· 4 days agoUltravate (halobetasol propionate) is a prescription drug that’s used to treat plaque psoriasis. Ultravate can cause side effects that range from mild to ...
State board targets six prescription drugs to review for affordability for Marylanders
Maryland Matters via Yahoo News· 4 days agoThe board will seek public comments, additional information and data over the next 60 days to...
TREMFYA® (guselkumab) QUASAR Maintenance Study in UC met its primary endpoint and all major...
FOX 23 News Albany· 4 days agoWASHINGTON, May 20, 2024 /PRNewswire/ -- Johnson & Johnson today announced the first data from the Phase 3 QUASAR Maintenance Study (Abstract #759) that showed 50.0 percent (p<0.001) of patients ...
UCB Announces Publication in The Lancet of Phase 3 BIMZELX® (bimekizumab-bkzx) Trials in...
KTLA-TV Los Angeles· 1 day agoIn these studies, bimekizumab consistently demonstrated sustained improvements...
Guselkumab Continues Winning Streak in Crohn's Disease
MedPage Today· 2 days agoInduction and maintenance treatment with guselkumab (Tremfya) demonstrated its safety and efficacy...